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ABSTRACT  
 
Bovine mastitis is one of the most prevalent and costly farm animals diseases that is widely 
spread all over the world, and a reason for concern for farmers and veterinarians, since it 
represents a great impact on cow welfare and in economic losses. Among all the pathogens 
that can cause mastitis, Streptococcus agalactiae and Streptococcus uberis are the most 
relevant. The main goal of this study was to analyze S.agalactiae and S.uberis isolates obtained 
from cows, that presented recurring mastitis infections. These cows were assayed at different 
time points in order to assess the molecular epidemiology of mastitis-causing pathogens. 
 
Bacterial virulence genotypes were found to be associated with mammary infections. For this 
reason, several virulence markers were tested with the collected isolates. For the putative 
S.agalactiae isolates the following markers were tested: the fructose operons FO1 and FO3; the 
toxin production CAMP factor; and the gene responsible for the adherence to epithelium, fbsB. 
The results obtained showed that a large percentage of S.agalactiae isolates contained these 
virulence factors in their genome. For the putative S.uberis isolates the following markers were 
chosen for testing: the gene responsible for the adherence to epithelium in this species, sua; the 
bacteriocin nisin U; the plasminogen activator pauA; the toxin production factor CAMP; and an 
antimicrobial resistance gene ermB. With the exception for the CAMP factor, all these genes 
were shown to be present in the large majority of of S.uberis isolates assayed. 
 
This work strengthens the hypothesis from previous studies concerning the high consistency 
and stability of these markers when used for identification of streptococci isolates. The obtained 
results suggested that there is a high prevalence of mastitis in the selected dairy herds, and that 
there are specific virulence patterns which are common amongst successful mastitis- causing 
pathogens. However, it was noticeable that pathogens with distinct virulence patterns were also 
able to cause recurring infections, meaning that infections apparently caused by atypical 
streptococci were also successful. 
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INTRODUCTION 
 
1.Bovine Mastitis 
 
Bovine mastitis is a disease that affects dairy herds worldwide and is a main concern for 
both farmers and veterinarians concerning animal welfare and economic losses. (Koskinen et 
al., 2009; Manthe, 2014; Reinoso et al., 2011; Taponen et al., 2009; Tomita et al., 2007). The 
disease consists in an inflammation of the mammary gland mostly due to the invasion of 
pathogenic microorganisms through the teat canal. Any kind of trauma or irritants can damage 
the skin around the teat, which contributes to break the first line of defense against external 
pathogens (Almeida et al., 2013). When pathogens enter the teat canal, they start to produce 
toxins, enzymes and surface proteins to promote adherence to the host tissue (Almeida et al., 
2013). These aggressions cause an inflammatory response characterized by an increase of 
somatic cells count (SCC), with release of interleukins, polymorfonuclear neutrofiles (PMN), 
phagocytes and leukocytes to fight against this aggression. In case of inflammation, around 
95% of cells present are PMN (Schukken, 2004).These inflammations interfere with the milk 
production and quality, reducing its economic value. 
Depending on the range of clinical signs, mastitis can vary from subclinical to clinical 
presentation, which also depends on the virulence of the pathogens and the host´s immune 
system ability to respond to invasion (Erskine, 2001). Regarding the reservoirs of pathogenic 
agents, these microorganisms can be divided in two categories depending on their behavior: 
contagious, if the microorganism spreads from cow-to-cow through fomites namely dirty or 
spoiled teat cups, milker`s hands or even milking machines, and environmental, if the infection 
occurs due to ubiquitous organisms, which are found in the animal housing environment. 
(Reinoso et al., 2011). Streptococcus agalactiae, Staphylococcus aureus, Streptococcus 
dysagalactiae and Mycoplasm are considered contagious agents, commonly causing longer 
and more prevalent infections. (McDonald,1979). Streptococcus uberis, Escherichia coli, 
Klebsiella, spp and Enterobacter, spp are considered environmental agents and usually cause 
more severe cases of clinical mastitis (McDonald, 1979). The above-mentioned bacteria belong 
to a group of major pathogens which cause the greatest milk alterations and economic losses. 
Coagulase-negative staphylococci and Corynebacterium bovis are examples of minor 
pathogens, usually not associated with large changes in milk parameters (Harmon, 1994). 
However recent studies suggest that the presence of these minor pathogens can increase the 
risk of intramammary infection by major pathogens (Reyer et al.,2012; Zadocks et al., 2001). 
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2.Streptococcus 
 
Streptococcus are gram-positive bacteria with particular traits such as being catalase-
negatives, facultative anaerobes and lactic acid producers. (Facklam,2002). These bacteria are 
usually commensal organism in mammalian skin membranes, such as the mucosa and skin 
surface. However, some behave as opportunistic bacteria and may cause infection if the host 
defense barrier is broken (Almeida et al, 2013, Porfírio, 2013).  
Although many streptococci have been identified as mastitis causative agents, 
Streptococcus agalactie and Streptococcus uberis are generally regarded as the most 
significant pathogens (Jones and Bailey, 2009; McDonald et al., 2005; Kuang et al., 2009; 
Unnerstad et al., 2009). 
 
2.1. Streptococcus agalactiae 
 
Streptococcus agalactiae is a pyogenic and contagious agent which causes mostly 
subclinic and also mild to moderate mastitis in ruminants. In general, cows infected with this 
pathogen present more than one affected quarter. These bacteria do not survive for long 
periods in the environment, nevertheless they can persist for undetermined time in mammary 
glands, if good practices are not implemented (Harmon,1994; Martinez et al., 2000; 
Ruegg,2005; Wilson et al.,1997). 
Streptococcus agalactiae belongs to Group B Streptococcus (GBS), which is a 
Lancefield´s classification for hemolytic streptococci. (Radtke et al.,2010). These opportunistic 
bacteria are able to cause disease in humans, both adults and children preferentially in 
pregnant women, diabetics, older people or immunocompromised patients. S.agalactiae, which 
is commonly found in genitourinary and gastrointestinal tracts, could also cause septicemia, 
meningitis and pneumonia in neonates, breast abscess formation and endocarditis in women, 
and soft tissue and osteoarticular infections in elderly adults (Glaser et al.,2002; Haguenoer et 
al.,2011; Radtke et al., 2010; Zadocks & Fitzpatrick, 2009; Zadocks et al.,2011). 
Several epidemiological and molecular studies have been conducted to analyze the 
persistence, transmission routes and reservoirs of human and cattle strains. Two hypotheses 
for the relation between these two groups of strains have been proposed, one postulates that, 
there is a direct transmission between cattle and humans and the other states that human 
strains evolved from bovine sources (Zadocks et al. 2011). 
In herds with a good health management plan, it is possible to completely eliminate 
Streptococcus agalactiae through the implementation of specific measures, namely prevent the 
spread during milking, by avoiding milking the infected cows first, and perform dry-cow therapy. 
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Additionally, these infections can be permanently eliminated with intramammary or injectable 
therapy (Keefe,1997). 
Infections cause by S.agalactiae decrease milk production and modify their parameters. 
In fact, a milk free of mastitis must have bellow 200x10e3 somatic cells per milliliter, and any 
increase of SCC in the bulk tank lead to pecuniary penalizations for the farmers (Jones & 
Bailey, 2009). 
 
2.2.Streptococcus uberis 
 
Streptococcus uberis is one of the most important causative agents of mastitis all over 
the world. As an environmental pathogen, S.uberis are spread to uninfected cows throuhgt their 
contact with contaminated surfaces in the animal housing (Peterson-Wolfe & Currin, 2012; 
Pryor et al.,2009; Tassi et al.,2013; Zadocks et al.,2001; Zadocks et al., 2005). 
This pathogen causes subclinical and clinical mastitis in lactating and non-lactating cows, with 
more emphasis in the dry period, calving and early lactation. There is an increased risk for new 
infections in the dry period and for cows in the lactating early period due to stress and 
postpartum low immunity (Oliver et al., 2004; Peterson-Wolfe & Currin, 2012; Zadocks et al., 
2003). Due to its ubiquitous nature, S. uberis is a very prevalent species, however the 
knowledge about its epidemiology is still incomplete (Phuektes et al., 2001; Reinoso et al., 
2011; Zadock et al., 2003). 
These bacteria can be found in many surfaces such as the bovine udder, excrements or 
bedding, therefore maintaining a clean and dry environment is very important to prevent the 
infection. Additionally chronic subclinical mastitis infection could also serve as a reservoir of 
contamination for healthy cows (Peterson-Wolfe & Currin, 2012; Zadocks et al., 2003), and 
many studies report that in some herds cow-to-cow transmission can be a vector of infection 
(Phuektes et al.,2001;McDougall et al., 2004; Zadocks et al., 2001). However in the animals 
which are not milked, like dry cows and preparturient heifers, this kind of transmission cannot be 
considered, making the environment the most likely source of infection (Zadocks et al., 2003). 
Bacterial typing studies revealed high serologically and biochemically heterogeneity in S. uberis 
( Zadocks & Fitzpatrick, 2009).Generally the persistence of infection and treatment failures can 
be attributed to adherence and invasion factors and and to this capacity to survive in mammary 
epithelial cells (Bentley et al., 1993; Zadocks & Fitzpatrick, 2009). 
Regarding treatment, long lasting antibiotics are nowadays widely used to control the 
risk of mastitis. Nevertheless, some studies refer that the use of an internal teat sealant and 
antibiotics treatments at dry off period could reduce the rate of new infections (Peterson-Wolfe 
& Currin, 2012).  
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Application of good management practices in herds have been successfully employed in 
order to reduce the effect of contagious agents, however, their success is limited towards 
controlling mainly environmental agents like Streptococcus uberis (Pitkälä et al., 2008; Tomita 
et al., 2007). 
 
3.Mastitis Resistance 
 
To prevent possible entries from pathogens, cow´s udders have some strategies of 
defense. The first one, which prevents the entry of pathogenic agents in the mammary gland, is 
the teat canal that provides a physical barrier and the sphincter muscle (within the teat canal) 
that helps to expel out this microorganisms through washing-out effect of milking and epithelial 
desquamation (Sandholm et al., 1995). Studies show that a higher ratio of milk flow leads to 
less probability of mastitis infections, mostly in the case staphylococcal and streptococcal 
infections. The size of the teat canal and strength of the sphincter muscle are crucial to prevent 
the bacteria from reaching the mammary gland cistern. The medium diameter of the teat canal 
is between 2.3 and 5mm, therefore there is an increased risk of mastitis in older cows as they 
have more dilated teat canals. Shorter teats milked faster and fuller and avoiding residual milk, 
therefore, decreasing the susceptibility to infection. Since the conformation of udders is 
heritable, and that deep and pendulous udders have more predisposition to higher SCC and 
mastitis (Seykora & McDaniel, 1985), extra care must be taken at the end of milking because 
the teat canal remain open for at least two hours, which contributes to an increase of ascending 
infections (Jones & Bailey, 2009; Sharif et al.,2009). 
Keratin, a fibrous protein with bacteriostatic properties, is present in lining cells of the 
teat, which greatly contributes to slow the possible progression of pathogens. Therefore, trauma 
or lacerations in the teat must be avoided, as they damage the cells producing keratin and 
mucous, which increases the risk of bacterial colonization (Jones & Bailey, 2009). One study 
found that there is about three times more prevalence of new infections by Streptococcus 
agalactiae in quarters with acute teat end lesions than in healthy or small lesion quarters. A well 
planned milking is a good practice in order to avoid teat trauma and further hyperkeratosis. 
Moreover, care should be taken, to not milk a dry quarter, as in addition to the improper 
stimulation of the animal, overmilking can predispose to erosion of the orifice and cause severe 
lesions which may lead to persistent subclinical mastitis (Neijenhuis et al., 2001; Seykora & 
McDaniel, 1985). The second line of defense, consists in the immunological properties of milk, 
which is not very favorable to the growth of bacteria. 
Genetics factors, udder health and lactation stage can interfere in the concentrations of 
important antibacterial enzymes and other molecules present in milk such as lactoperoxidase, 
lysozyme, lactoferrin, transferrin, immunological defense mechanisms and the complement 
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system (Sandoholm et al.,1995). In case of inflammation, many mediators migrate through 
circulatory system to quell the infection, such as prostaglandins, leukotrienes, interleukines 
(IL17), lympocytes, neutrophyles, phagocytes,PMN leukocytes, major histocompatibility class I 
and II and toll-like receptors (Tassi et al., 2013; Zadocks & Fitzpatrick, 2009). However it should 
be noted that PMN leukocytes and phagocytes are attracted in a wide number to milk which 
causes an increase of somatic cells count (SCC). Moreover, substances released by PMN 
destroy the alveolar structure that upon healing turns into cicatrization tissue, which can be 
problematic for antibiotic treatment (Jones & Bailey,2009). 
Specific cow characteristics influence the onset of mastitis and increase the duration of 
clinical mastitis namely genetics, parity,age, negative energetic balance, immune status, 
nutritional status, deficiencies of some components of diet like selenium, E vitamin, α or β 
carotene (Abureema et al., 2014; Hagnestam-Nielsen et al., 2008; Harmon,1994; Zadocks et 
al.,2001). 
Lactoferrin and transferrin are two important iron binding proteins that are part of 
antibacterial defense, preventing bacterial growth by competition against bacterial iron uptake. 
In case of mastitis, their concentration in milk increases considerably. Lactoperoxidases are 
enzymes responsible for the oxidation of bacterial cell wall componentes. These enzymes are 
regulated by the concentration of hydrogen peroxide which formation is inhibited by the low 
oxygen pressure in case of mastitis.  
Lysozyme is an antimicrobial enzyme, that regardless their small concentration in milk, 
causes the hydrolysis of the bacterial cel wall causing the osmotic lysis of bacteria (Sandholm et 
al., 1995). 
 Altogether these studies show that in case of infection, milk composition is altered. An 
increase in vessels permeability and SCC and, a decrease of some components such as 
lactose, α-lactalbumin, fat, casein and calcium translate in an impairment of milk quality 
(Harmon, 1994). 
 
4.Bacterial tools to successfully infect the host 
 
From the moment bacteria invades the teat canal and reach the milk cistern, a complex 
process of adaptation is started. In general, when the udder´s defense is broken this is due to 
several bacteria species. These bacteria compete with each other seeking dominance to 
successfully infect the host. To accomplish this task, many virulence factors are induced in 
order to enhance the host invasion, i.e., to resist to the immune response from the host; to 
grown in milk; to adhere to the mammary epithelial cells; and to resist phagocytosis (Pryor et 
al.,2009). Therefore, an in depth analysis of virulence factors allows for an enhanced 
understanding of the adaptation of S.agalactiae and S.uberis in the mammary gland.  
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Bacteria with a good adherence and invasion capacity are more fit to ensure their spread 
in the host, therefore their virulence aptness is increased when these factors are present 
(Sandholm et al., 1995). Not surprisingly, bacteria production of surface adhesins, like 
fibrinogen, is extremely valuable at the early stages of infection, as they allow to counteract the 
flushing effect during milking or the phagocytic action, both of which, constitute barriers to 
bacterial propagation (Patti et al., 1994). 
 
4.1 Invasiveness patterns 
In S.agalactiae, several families of fibrinogen binding proteins (Fb) have been studied, 
namely the fibrinogen binding protein A (FbsA) and fibrinogen binding protein B (FbsB) (Devi et 
al., 2010; Porfírio, 2013). FbsA promotes binding to the human Fb, and FbsB has a terminal 
region that binds only in bovine Fb. Binding is increased by calcium, which is present in milk 
(Devi et al., 2010; Jacobsson et al., 2002; Porfírio,2013). 
In S. uberis, Sua is an adhesion molecule with high affinity to lactoferrin (Almeida et al., 
2006). Lactoferrin (LF) is an iron binding glycoprotein present in milk, known for their 
bacteriostatic, bactericidal, antifungal, antiviral, antitumural and immunomodulating properties, 
which takes part in the innate immune response. LF is synthesized by glandular epithelium cells 
in the mammary gland and studies show that infected quarters present higher concentrations of 
LF. Additionally, it is reported that, S uberis can induce LF synthesis in milk enhancing its 
resistance to lactoferrin activity, which confers an advantage over competing bacteria 
(Chaneton et al., 2008). 
Pathogens with an hyaluronic capsule, are protected from host defence to some extent, 
because neither antibodies or complement factors can attach to the bacteria surface and 
perform the recognition before phagocytes (Sandholm et al., 1995; Ward et al.,2001). Three 
genes are involved in the production of a hyaluronic acid capsule: hasA, hasB and hasC. (Ward 
et al., 2001). In S.uberis, the capsule production requires the presence of both hasA and hasC 
genes (Field et al., 2003), however, studies refer that in S.uberis the presence of an hyaluronic 
acid capsule is not essential for a successful infection (Ward et al., 2009). 
 
4.2- Virulence patterns 
Streptococcus agalactiae has the ability to quickly adapt to adverse conditions in the 
host, such as osmolarity, pH, starvation, temperature variations and oxidative stress, through 
the synthesis of proteins that act as proteases and chaperones. 
For their growth, bacteria need to import some carbon sources, and in S. agalactiae the 
sugar specific phosphoenolpyruvate-dependent phosphotransferase system (PTS) enzyme II 
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complexes like lactose, fructose, glucose or mannose can be used for this purpose (Glaser et 
al., 2002). 
In the absence of the primary source of carbon (carbohyrdrates), lactose and fructose 
can help to supply energy, however, only bovine strains present this fructose utilization 
pathway. In the utilization of fructose, a four-gene operon is involved: the phosphotransferase 
system fructospecific IIA componente (fruD), the fructose-specific IIBC PTS component (fruC), 
the fructose-1-phosphate kinase (fruP) and a transcriptional regulator (fruR) (Richards et al., 
2011). The fructose and lactose operons in S.agalactiae display high sequence homology 
(99%) with the ones present in other bovine mastitis causative bacteria, which suggests that 
lateral gene transfer (LGT) between different species can occur in the udder (Zadocks et al., 
2011). 
Extracellular proteins have been acknowledged as virulence factors, due to their ability 
to bind host proteins and provide resistance against reactive oxygen species produced by 
phagocytic cells. These proteins also allow bacterial growth, due to their capacity to break down 
glucose as a carbon source and to obtain energy, in addition to conferring protection to the host 
immune system (Holzmuller et al.,2006; Madureira et al.,2007; Pancholi & Fischetti, 1992). The 
glyceraldehyde-3-phosphate dehydrogenase, (GAPDH) is one of those proteins and is present 
both in S. uberis and S.agalactiae (Ling et al., 2004; Maeda et al., 2004; Reinoso et al., 2011). 
Concerning toxin production, the CAMP factor is one of the most studied in S.agalactiae and 
S.uberis. The CAMP factor is a pore forming protein, which can cause the phospholipidic 
hydrolysis of the red blood cells membrane and lead to cell lysis (Lang & Palmer, 2003). 
S.uberis is unable to grow in milk, unless is able to hydrolyze host proteins. Therefore, 
S.uberis uses a caseinolytic enzyme (plasmin) in order to acquire the essential nutrients 
necessary for growth. The extracelular plasminogen activator (PauA), hydrolyses plasminogen 
to plasmin allowing the release of amino essential acids and peptides from host proteins (Leigh 
et al., 1993; Smith et al., 2002). This means that bacterial growth in milk might not be possible 
without an intact oligopeptide transport system, whose function is the acquisition and 
accumulation of amino acids within the bacteria. These bacterial oligopeptide permeases (opps) 
include five proteins: oppA, oppB, oppC, oppD and oppF. In particular, oppF seems to play an 
important role in providing energy for peptide substrate transportation, allowing the growth of 
S.uberis in milk (Smith et al., 2002; Reinoso et al., 2011). 
Bacteriocins are antimicrobial peptides produced by bacteria in response to direct 
competition between strains, which are able to inhibit the growth of the same or related species. 
Uberolysin and nisin U are the most studied bacteriocins (Wirawan et al., 2006). Studies have 
shown that strains that produce nisin U, are usually predominant in case of infection showing 
that the production of nisin U leads to a competitive advantage in intramammary infection (Pryor 
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et al., 2009). Paradoxally,only a few strains of S.uberis seem to have the capacity to produce 
nisin (Wirawan et al., 2006). 
 
5.Mastitis control programs 
 
Bovine mastitis is a major cause for concern among veterinarians and producers 
because it affects both the quality and the quantity of milk produced by dairy herds (Giraudo et 
al., 1997). New mastitis control programs have been implemented in herds, which includes 
antibiotic and prophylactic therapy, postmilking teat disinfection and culling of chronically 
infected cows. These programs have been very successful in controlling cases of contagious 
pathogens like Streptococcus agalactiae; however the application of these measures are less 
effective regarding the control of environmental pathogens, such as Streptococcus uberis 
(Phuektes et al., 2001;Oliver et al., 2004). 
It is very important that livestock producers receive specialized training in order to better 
understand and apply all the required preventive measures (Cerqueira et al., 2011). 
The Californian Milk Test (CMT) is one of the most commonly used methods to evaluate 
subclinical mastitis by providing an estimate of somatic cells present in milk samples (Kuang et 
al., 2009; Pyorälä, 2003). The reaction in which the test is based consists in the interaction 
between the somatic cells resultant from an inflammatory response, and reagent/detergent 
(usually Bromocresol) together with a pH indicator. In case of subclinical mastitis, a higher 
somatic cells count in the sample, promote the formation of a gel in CMT racket. 
This test is very useful because, besides to be very easy to perform, it allows the farmer to 
identify the risk animals and collect their milk samples for further analyses, thus contributing to 
improve herd control programs in management and animal health (Brito et al., 1997).  
Other preventive measures can also be taken by farmers namely avoiding the entry of 
flies in the barn, since these insects can act as a disease transmission sources. Moreover, so 
some attention must be given to humid and cool places, carry out animal segregation during 
milking to reduce the contact between ill and healthy cows (Sharif et al., 2009; Zadocks, et al., 
2001) and perform periodic maintenance to milking machine in order to avoid vacuum 
fluctuations and overmilking (Giraudo et al. 1997; McDonald, 1979). 
Treatment with antibiotics is widely spread in farms, and some studies show that 
antimicrobial treatments reduce the SCC and present higher bacterial cure rates and lower the 
risk of premature culling when administered intramuscularly compared to intramammary 
application (Pantoja et al.,2009; Sandgren et al., 2007).The supervision of a veterinary during all 
drug treatments is crucial for the success of antibiotics treatment as an efficient control measure 
(Rajala-Schultz et al., 1999). However, proper identification of pathogens is required to correctly 
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apply the most suitable drug, taking into account resistance and susceptibility to antibiotics by 
specific pathogens (Pitkälä et al., 2008). 
Efficient treatment of clinical mastitis depends on several factors that the veterinarian 
must be aware, namely, the cow traits (age, state of lactation, immune response, SCC), the 
pathogen (pathogenicity, response to therapy and virulence factors), and drugs (spectrum, 
route, concentration and duration). Therefore a better understanding of all these factors 
increases the success of treatments (Barkema et al.,2006; Pinzón-Sanchez & Ruegg, 2011).  
Concerning resistance to antibiotics, several studies have reported that resistance to 
gentamicin, erytromicin, pirlimycin and tetracycline are the most common (Minst et al., 2012). In 
steptococci, the most usual macrolide resistance mechanism is a modification in ribosomes 
mediated by a methylase that is encoded by an erm gene (mainly ermB), which confers 
resistance to erythromicin and inducible resistance to streptogramin B and lincosamins (Duarte 
et al.,2004; Roberts et al., 2002; Weiseblum et al., 1985). Some streptocci are multidrug 
resistant, but resistance rates are lower in S.agalactiae than in S.uberis. Farms with more than 
eigthy cows have more apparent antibiotic resistance. A good choice for treatment appears to 
be penicillin and ampicillin due to is lack of resistance in herds, so β-lactamics remain the drugs 
of choice for treatment of these pathogens (Minst et al., 2012). 
The application of the five point plan mastitis control program allowed for a rapid 
progress in reducing subclinical and clinical mastitis in herds all over the world (Barkema et al., 
2006; Fernández et al., 2013).  
 
6. The role of molecular biology in veterinary epidemiology 
 
Molecular epidemiology is an interdisciplinary approach of paramount importance in 
order to ascertain causes, patterns, distribution and effects of infectious or non-infectious 
diseases in populations, either human or animal, using molecular biology methods and 
encompassing disciplines as molecular biology, population genetics and epidemiology 
(Foxmann & Riley, 2001; Riley, 2004). 
In recent years bioinformatics tools are being widely used in molecular epidemiology, 
allowing to process, analyze and organized efficiently any kind of molecular typing data. One of 
the greatest advantages of molecular tools is the ability to process a large number of strains or 
to analyze simultaneously several loci while generating unequivocal data that can be stored and 
shared for further studies. Additionally, the integration of all this information can be used to 
generate epidemiological models that could contribute to understand epidemiological factors of 
persistent pathogens and their behavior through space and time (Muellner et al., 2011; Archie et 
al., 2009). 
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 As mentioned above, bovine mastitis can be caused by either contagious or 
environmental pathogens, Streptococcus agalactiae and Streptococcus uberis respectively, and 
it is essential for the veterinarian to understand the diversity and behavior of these species, in 
order to develop effective control measures and conduct a good prophylaxis to prevent future 
infections. In this regard, molecular studies are invaluable to characterize differences between 
and within infectious bacterial species, and to unveil virulence factors, transmission and 
adapting mechanisms (Muellner et al., 2011; Rato et al., 2008). The data are particular helpful 
to assist veterinarians overcoming important barriers encountered in clinical practice, as it is the 
efficient use of antibiotics (Frye et al., 2000) 
 
7. Main goals to achieve 
 
The main objectives of this project were: 
 To characterize important virulence markers in S.agalactiae and S.uberis. 
 To test the markers previously characterized in new isolates and confirm the presence 
of important virulence factors. 
  To monitored selected animals previously known to be positive to Streptococcus 
agalactiae or Streptococcus uberis and evaluate the taxonomic and genotyping identity 
of reisolates that might reveal possible differences in adaptation and persistence of 
strains. 
 To gather as much clinical information as possible from the infected animals in order to 
correlate with disease prevalence and with bacterial lineages that might contribute to 
unveil informative epidemiological disease patterns. 
 
 
MATERIALS AND METHODS 
 
1. Milk samples and bacterial isolates 
 
For this study four dairy herds in an intensive system were selected, two of them had 
mostly isolates of S.agalactiae (Barcelos and Póvoa do Varzim), while the other two had 
Streptococcus uberis (Barcelos and Maia). 
 From November 2013 to April 2014, herds were visited once a month, with occasional 
exceptions, to monitor and evaluate the morning milking. The general state of lactation cows 
was evaluated, CMT was performed (Brito et al., 1997) to determine the SSC. A numeric scale 
was used for SSC: 0 to normal milk, 1 to medium SSC and 2 to a severe SSC. Lactating cows 
were also screened for signs of clinical mastitis and a dichotomous scoring alphanumeric 
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system was used to classify the general state of cows and milk features: 1=abnormal milk, 2 = 
abnormal milk plus inflamed quarter, 3 = abnormal milk plus inflamed quarter and systemic 
illness and a letter A = milk with flakes, B = presence of clots, C = watery discharge and D= 
bloody discharge (Shukken & Welcome, 2004). 
Before collecting the milk samples the teat ends were disinfected with cotton soaked in 
alcohol (70 %) and around 20 ml of milk were collected (5ml from each quarter for composed 
samples, or 20 ml from a specif quarter in follow-up analysis). All the samples were sent to 
SEGALAB (Laboratório de Sanidade Animal e Segurança Alimentar, S.A), to perform the 
counting of somatic cells and to identify bacterial isolates using the VITEK 2 system 
(bioMérieux, Durham, NC).  
During the mentioned period and for this work a total of 233 bacterial isolates were 
obtained, 158 from S. agalactiae end 75 from S. uberis. As the central objective of this work 
was to study the bacterial isolates from the same infected cows at different time points, special 
emphasis was placed on the analysis of these isolates. 
Five strains listed in Table I and previously characterized by Almeida et al., 2013 were 
used as controls. 
 
Table I - Bacterial strains used as controls (Almeida et al., 2013) 
Strain  Species Location  Source 
SA A9 Streptococcus agalactie LMG 15083 - LMG 
SA7 Streptococcus agalactie Vila do Conde SEGALAB 
SUA12 Streptococcus uberis LMG 9465 - LMG 
SU3 Streptococcus uberis Barcelos SEGALAB 
SAUR1 Staphylococcus aureus LMG 8224 - LMG 
LMG- Belgian Co-ordinated collections of microorganisms, Gent, Belgium. 
 
2. Bacterial culture conditions and DNA extraction 
 
All the samples identified as S.agalactiae or S. uberis by the VITEK 2 system were 
cultured in Brain Heart Infusion (BHI) (biolab®, Hungary) at 37ºC. After growth in BHI medium, 
all isolates were stores at -80ºC in 20% glycerol. 
DNA was extracted from pure cultures using the E.Z.N.A bacterial DNA purification Kit 
(Omega Bio Tek, Norcross, GA), following the manufacturer’s instructions. The Qubit 2.0 
Flurometer HS Assay (Invitrogen, Carlsbad, CA) was used to quantify the extracted DNA, and 
the quality was assessed by electrophoresis using 1% agarose gels stained with GelRed 
(Biotum). Gel images were obtained using a Gel-Doc system (Bio Rad).  
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3. PCR amplification 
For amplification of the cfb (CAMP factor) and pauA genes, primer-pairs were designed 
using the Vector NTI software (Invitrogen, Carlsbad,CA.) and synthetized by STABVida (Lisbon, 
Portugal). Amplicon specificity was confirmed using the BLAST software (Basic Local Alignment 
Search Tool) (Altschul,1990) (BLAST, http://blast.ncbi.nlm.nih.gov/).  
The PCR master mix contained 1x Dream Taq buffer, containing 1.5mM of MgCl2 
(Fermentas, Ontario, Canada), 0.2mM of each dNTP (Fermentas), 0.2µM of each primers 
(forward and reverse) and 1U of DreamTaq DNA polymerase (Fermentas). 25ng of bacterial 
DNA from pure bacterial cultures were used in each reaction. The PCR conditions were as 
follows: an initial denaturation of 95ºC for 5 min, 35 cycles at 90ºC for 30s, 55ºC for 30s, 72ºC 
for 45s, followed by a final extension of 10min at a temperature of 72ºC. 
PCR products were visualized in 1.5% agarose gels stained with 3µl of GelRed 
(Biotum®) the expected bands were cut using a scalpel and purified using the Ilustra® GFX™ 
PCR DNA and Gel Band Purification Kit (GE Healthcare, Buckinghamshire, UK). To confirm 
their identity these amplicons were sequenced by STABVida (Lisbon, Portugal).  
 
Table II- Taxa specific and functional markers and PCR primers sequences  used in this study. 
Molecular 
markers 
Primers sequence (5’-3’) Ta 
Amplicon 
Lenght 
Target 
gene 
Reference 
F1-SAA9 
Fwd TTATGCTCGTCTTGCTCTTTACGG 
56ºC 285 bp - 
Almeida et al., 
(2013) Rev GCACACGTCCAAGTGATGTAGCTG 
F1 
Fwd TTATGCTCGTCTTGCTCTTTACGG 
54,6ºC 285 bp - 
Almeida et al., 
(2013) Rev GCACACGTCCAAGTGATGTAGCTG 
SU 
Fwd TCGTTTGTATACGCTTGARGCT 
50,6ºC 229 bp - 
Almeida et al., 
(2013) Rev CACGTCTCTATAAAAGGAATTCCC 
A1 
Fwd ATGTAGCTGCTGATTCTGTCATAA 
52,6ºC 314 bp - 
Almeida et al., 
(2013) Rev AATAGCTGGTGTAGATTTGACTGC 
sua 
Fwd TCAGTTGTTGTGATTGCTGACGTC 
56,0ºC 600 bp sua Porfírio,2013 
Rev CAAACAAGTGGTTTCAGGTCCATT 
fbsB 
Fwd ACAAAGTTCAGTTGCGCAAACT 
52,9ºC 525 bp fbsB Porfírio,2013 
Rev CGCGATGAGATTGATTTACTCA 
FO1 
Fwd TCCACCACGTTATTGAGAGTTT 
50,6ºC 331 bp fruR 
Richards et al., 
(2011) Rev TCTCAATTTCTTCGATCTCATGTGC 
FO3 
Fwd TCTCAATTTCTTCGATCTCATGTGC 
52,6ºC 348 bp fruD 
Richards et al., 
(2011) Rev CAGGTCTTGTTGTCGAAAACGATTA 
NU1 
Fwd CCAAGGTTGCAGCGCATTT 
51,5ºC 331 bp nsuR 
Richards et al., 
(2011) Rev CCCCTTATTGTCTTGATGGGATT 
NU3 
Fwd AATCAAATCGTTGATGAAAATGACC 
50,6ºC 502 bp nsuF 
Richards et al., 
(2011) Rev AAACTTCTCCGTAATCCCAAACTTC 
V1 
Fwd TGCTTGGTGACGATTTGATG 
58,0ºC 300 bp hasC 
Ward et al., 
(2001) Rev GTCCAATGATAGCAAGGTACAC 
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V2 
Fwd GCTCCTGGTGGAGATGATGT 
55,0ºC 189 bp gapC 
Reinoso et al., 
(2011) Rev GTCACCAGTGTAAGCGTGGA 
V3 
Fwd GGCCTAACCAAAACGAAACA 
54,0ºC 419 bp oppF 
Smith et al., 
(2002) Rev GGCTCTGGAATTGCTGAAAG 
CAMP 
Fwd GGATTCAACTGAACTCCAACAGCA 
57,0ºC 614 bp cfb/cfu This study 
Rev CATGCTGATCAAGTGACAACTCCA 
pauA 
Fwd TTTTGGGAATATTTGGTTGTGC 
55,0ºC 427 bp pauA This study 
Rev TCAACCCGTTTTCTGAGAATAA 
 
4. Dot-Blot screening 
 
Purified PCR products were labelled with digoxigenin to obtain DNA probes, using the 
DIG-High Prime labelling kit (Roche, Basel, Switzerland) according to the manufacturer´s 
instructions. For marker F1, a family-specific marker previously validated (Almeida et al., 2013), 
a new probe was obtained using as template DNA from S. agalactiae SAA9. 
To perform the Dot-Blot hybridization 100ng of heat-denatured DNA from each bacterial 
strain was spotted into a nylon membrane optimized for the transfer of nucleic acids (Amersham 
Hybond™-N GE Healthcare, Buckimghamshire,UK), using a Bio-Dot apparatus (Bio Rad) 
(Tables III, IV and V). Hybridization was carried out over night at 68ºC, using 100ng/ml as the 
final probe concentration. Washing and detection of the membranes were performed according 
the recommendations of the DIG system (Roche). DIG-labeled nucleic acids were detected by 
chemiluminescence using X-ray films (GE, Healthcare) and a Molecular Imager Chemi-Doc 
system (Bio Rad). 
In order to analyze the obtained results, an image processing algorithm was used. 
This software uses as references both the positive and negative controls present in the 
membranes and, calculates the probability of each dot being a positive signal. The exposure 
time in the Chemi-Doc system was adjusted to ensure that all dots were below pixel saturation 
(Albuquerque et al.,2011). 
 
Table III- Layout of the first Streptococcus agalactiae membrane used in the dot-blot hybridization assay 
  1 2 3 4 5 6 7 8 9 10 11 12 
A SA7 SA253 SA329 SA335 SA254 SA322 SA332 SA344 SA202 SA203 SA204 SA7 
B TE SA205 SA326 SA327 SA328 SA257 SA330 SA331 SA336 SA337 SA154 TE 
C SA194 SA195 SA196 SA197 SA323 SA324 SA325 SA258 SA319 SA334 SA346 SA255 
D SA320 SA321 SA333 SA345 SA318 SA343 SU112 SA38 SA275 SA276 SA277 SA221 
E SA222 SA283 SA284 SA285 SA286 SA67 SA68 SA232 SA233 SA270 SA271 SA272 
F SA243 SA244 SA295 SA35 SA223 SA296 SA249 SA250 SA251 SA252 SA307 SA308 
G TE SA309 SA310 SU16 SA58 SA218 SA219 SA266 SA267 SA234 SA306 TE 
H SA7 SU113 SA56 SA245 SA246 SA247 SA248 SA311 SA312 SA313 SA314 SA7 
SU112, SU16 and SU113- negative controls. 
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Table IV- Layout of the second Streptococcus agalactiae membrane used in dot blot hybridization assay. 
 
1 2 3 4 5 6 7 8 9 10 11 12 
A SA7 SA207 SA260 SA224 SA225 SA226 SA227 SA302 SA303 SA304 SA305 SA7 
B TE SA50 SA237 SA238 SA239 SA240 SU52 SU58 SA57 SA300 SU16 TE 
C TE SA59 SA241 SA242 SA280 SA281 SA282 SU90 SA43 SA214 SA301 TE 
D SA7 TE TE TE TE TE TE TE TE TE TE SA7 
   SU52, SU58, SU16 and SU90- negative controls. 
  
 Table V- Layout of the Streptococcus uberis membrane in the dot blot hybridization assays 
 
1 2 3 4 5 6 7 8 9 10 11 12 
A SU3 SU57 SU91 SU114 SU52 SU53 SU58 SU59 SU16 SU112 SU90 SU3 
B TE SU113 SA283 SU76 SU80 SU72 SU73 SU89 SU70 SU86 SU63 TE 
C SU64 SU65 SU82 SU83 SU67 SU103 SA284 SU40 SU62 SU79 SU99 SU66 
D TE SU81 SU105 SU45 SU101 SU42 SU43 SU69 SU85 SU48 SU49 TE 
E SU3 SU68 SU87 SU88 SU104 SA285 SU60 SU61 SU84 SU98 SA286 SU3 
.SA283, SA284, SA285 and SA286- negative controls. 
 
5. CAMP test 
 
The CAMP test is a presumptive identification test of S. agalactiae (Lancefield group B). 
(Phillps et al., 1980, Ratner et al., 1986). 5% sheep blood agar was used as cultured medium. 
This test consists in a synergistic lysis of sheep erythrocytes between Staphylococcus aureus 
and a protein from group B S. agalactiae, the CAMP factor (pathogenicity factor) (Gase et 
al.,1999). A positive result is verified by the presence of a halo which confirms β-hemolysis. To 
perform this assay, a strain of S. aureus LMG 8224 was placed in the center of a culture plate, 
and four strains of S.agalactiae two on each side were placed 3 mm perpendicularly to the 
strain, without direct contact. Streptococcus uberis, Bacillus subtillis and Klebsiella pneumonia 
were used as negative controls. The plates were incubated overnight at 37ºC. A total of seventy 
two strains were tested in eighteen petri dishes (Table VI). 
Only one strain (1.4%) presented a negative result (SA311) (Figure 1). Sequencing of 
the 16S rRNA gene allowed identifying SA311 as Staphylococcus epidermidis. (Weiseburg et 
al., 1991) This analysis showed that this strain was misidentified as S.agalactiae by the VITEK 
system. 
 
Table VI- Scheme used for plating the strains in petri dishes. 
Plate 1  Plate 2 Plate 3 Plate 4 Plate 5 Plate 6 Plate 7 Plate 8 Plate 9 
SA214 SA232 SA223 SA211 SA246 SA238 SA43 SA190 SA194 
SA215 SA233 SA252 SA94 SA247 SA239 SA59 SA191 SA195 
SA216 SA207 SA218 SA56 SA50 SA241 SA68 SA192 SA196 
SA217 SA243 SA219 SA245 SA237 SA242 SA93 SA193 SA197 
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Plate 10 Plate 11 Plate 12 Plate 13 Plate 14 Plate 15 Plate 16 Plate 17 Plate 18 
SA198 SA202 SA208 SA300 SA304 SA308 SA312 SA316 SA321 
SA199 SA203 SA297 SA301 SA305 SA309 SA313 SA317 SA322 
SA200 SA204 SA298 SA302 SA306 SA310 SA314 SA318 SA323 
SA201 SA205 SA299 SA303 SA307 SA311 SA315 SA319 SA324 
 
                            
Figure 1 – Example of the CAMP test plates. The central strain is Staphylococcus aureus LMG 8224, and  the arrow 
head shaped hemolytic halo associated to the Streptococcus agalactiae isolates is indicative of a positive result. The 
isolated cultured in the right side of the petri plates middle is a negative control, and the strain in the right bottom is a 
CAMP factor negative (XJ7- corresponding to isolate SA311). 
 
RESULTS 
 
1. Mastitis frequency in herds 
 
Milk quality programs have been increasingly implemented on farms in order to reduce 
clinical mastitis and decrease the CCS in milk. To accomplish this task, veterinarians are 
expected to visit frequently the farms, in order to evaluate the general health state of cows and 
to collect milk and bulk tank samples to search for pathogenic agents causing clinical and sub-
clinical infections. 
In this study, several visits to the four selected herds (A, E, F and Z) were carried out in 
order to select cows diagnosed with mastitis caused by S.agalactiae and S. uberis in 
consecutive visits. The results obtained from this study showed that, from a total of 154 isolates, 
only 3.9% were responsible for clinical mastitis. Additionally, it was shown, that the average 
somatic cell count was higher in farms prevalent for S.uberis, than in farms where mastitis was 
predominantly caused by S.agalactiae. Regarding data analysis, S.agalactiae infections 
presented both the highest and the lowest SCC. The lowest SCC are easily unnoticed, as the 
threshold of detection of mastitis is 200.000 somatic cells per milliliter (Table VIII). Concerning 
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bacterial virulence patterns, it was possible to observe that for each pathogenic agent, both 
S.agalactiae and S.uberis, there are some virulence patterns that are more common amongst 
cows, and that there are some virulence patterns that cause an elevated count of SCC, which 
translates in a more severe mammary gland infection (Table IX).   From the 4 herds studied, 37 
cows were diagnosed with mastitis in repeated visits, from which, 22 cows infected with 
S.agalactiae and 15 with S.uberis (Table VII). 
 
Table VII- Grid showing the selected cows for this study. 
Herds Visits Months Cows 
Samples collected 
Locality Agent 
All Quarters 
A 3 
Dec/13 
14 
29 1 
Barcelos S. agalactiae jan/14 33 0 
mai/14 not valued not valued 
E 5 
nov/13 
4 
2 0 
Barcelos S. uberis 
Dec/13 3 0 
jan/14 0 0 
Feb/14 2 0 
Apr/14 0 3 
F 4 
Dec/13 
8 
8 5 
Póvoa do Varzim S. agalactiae 
jan/14 13 1 
mar/14 6 0 
Apr/14 0 4 
Z 4 
nov/13 
11 
6 0 
Maia S. uberis 
jan/14 13 1 
Feb/14 11 0 
Apr/14 0 6 
nv- not valued 
 
Table VIII- Data analysis of simple and composed samples. 
Agent Statistics AD AE PD PE ALL 
S. uberis 
Mean 1416,5 5945,5 1568,7 883,2 1071,3 
St. Deviation 1206,69 4917,64 1691,27 372,10 889,80 
Maximum 3782 12914 5498 1156 3457 
Minimum 172 223 165 138 135 
S. agalactiae 
Mean 2121,3 435,7 1496,4 1420,2 1175,6 
St. Deviation 3128,13 394,97 1921,68 1315,35 2441,19 
Maximum 10077 1575 5725 4913 9153 
Minimum 106 104 85 60 50 
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Table IX- Data analysis showing strain code, number of isolates and respective mean of SCC.  
Streptococcus uberis Streptococcus agalactiae 
Strain Code Counting Mean of SCC Strain Code Counting Mean of SCC 
1 1 5147 12 1 11200 
2 37 1952 3 2 3138 
3 4 1619 7 1 1306 
6 1 374 1 94 1276 
4 3 262 4 1 941 
5 1 230 9 1 828 
  
 
  13 1 427 
  
 
  11 1 355 
  
 
  8 2 282 
  
 
  10 2 173 
  
 
  6 1 50 
Total  47 1848 Total  107 1329,4 
 
2. Preliminary tests 
In order to assess the efficiency of taxonomic DNA markers for rapid identification of 
mastitis isolates, all the strains collected in this work were tested by dot blot assays. 
Results corresponding to markers- V1, V2,V3 and SU showed that all these markers 
gave positive hybridization signals with all S.uberis strains tested. Marker NU3, which is specific 
for S.uberis, as expected, was negative for the tested S.agalactiae strains. Due to inconsistent 
results obtained with marker F1, a new F1 probe obtained from a S. agalactiae strain (SAA9) 
was labeled and tested. This new labelled taxonomic marker previously reported to be genus-
specific for Streptococcus, provided positive results with all tested strains (data not shown). 
 
3. Assays with selected strains 
 
3.1- Taxonomic markers 
 
Concerning the taxonomic and virulence analyses of all selected strains, three types of 
dot-blot membranes were made, two for S.agalactiae, due to its higher number of isolates, and 
one for S.uberis. The markers selected for testing with the S.agalactiae membranes were 
F1SAA9, A1, CAMP, fbsB, FO3 and FO1. For S.uberis membrane F1SAA9, CAMP, NU1, pauA, 
sua and ermB were the markers used for the hybridization assays. 
Regarding the probability values of hybridization outputted by the image analysis 
software used, a color code was employed to evaluate the obtained results 0 to 0.25 - low 
probability, represented in red, 0.25 to 0.75 -average probability, represented in yellow and 0.75 
to 1.00-high probability, represented in green. 
 A total of 110 isolates of S.agalactiae and 48 isolates of S.uberis were tested. For 
S.agalactiae membranes, the S.uberis isolates SU112, SU113, SU16, SU52, SU58 and SU90 
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were used as negative controls (these strains were also tested in S.uberis membranes). For 
S.uberis membrane, the S.agalactiae isolates used negative controls were SA283, SA284, 
SA285 and SA286, which were also evaluated in S.agalactiae membranes. 
A preliminary analysis of the obtained hybridization data revealed that the results 
obtained with three isolates previously identified by the VITEK system as S.agalactiae (SA332, 
SA272 and SA311) and one isolate identified as S.uberis (SU48), were indicative of a 
misidentification, as shown in Table X. In fact, 16S rRNA gene sequencing of the isolates, 
showed that these bacteria were incorrectly identified by the VITEK system and were withdrawn 
from further analysis. 
 
 
Table X- Isolates with atypical results in Dot-Blot membranes, that after 16S gene sequencing analysis, were 
withdrawn from this study. 
Streptococcus uberis membrane 
    
Strains ermB sua pau_A NU1 CAMP 
F1 
(SAA9) 
16S analysis 
SU48 0,04 0,00 0,00 0,00 0,00 0,00 Enterococcus 
        Streptococcus agalactiae membrane 
    
Strains FO3 FO1 fbsb CAMP A1 
F1 
(SAA9) 
16S analysis 
SA332 0,03 0,00 0,00 0,00 0,00 0,99 Streptococcus uberis 
SA272 0,10 0,16 0,06 0,01 0,03 1,00 Streptococcus uberis 
SA311 0,01 0,06 0,00 0,01 0,04 0,01 Staphilococcus epidermidis 
 
Regarding Streptococcus specific taxonomic marker F1 SAA9, dot blot hybridization 
showed a specificity of 99.1% (106/107) in S.agalactiae membranes, with only one isolate 
presenting a very low probability value of hybridization. However, when tested for marker A1, a 
taxonomic marker specific for this species, i.e. S.agalactiae, the result was a positive 
hybridization allowing to confirm the identity of this isolate. 
Marker A1, had a specificity of 92.5% (99/107), with eight isolates, 7.5% (8/107), 
presenting an average hybridization probability.  
In S.uberis membrane, the only taxonomic marker tested, F1 SAA9, present a specificity 
of 98% (46/47). 
 
3.2- Virulence markers 
A survey of the literature, allowed to select several virulence factors that seem to play an 
important role during mammary gland infections. In the present study, regions related to 
adhesion and invasion, toxin production, ability to growth in milk or in the environment and 
production of bacteriocins were selected for analysis. 
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In S.agalactiae membranes, concerning adhesion and invasion to the epithelium, the 
fibrinogen binding protein (fbsB) probe was selected. In S.uberis membrane the adhesion 
molecule (Sua) was tested. 
Concerning toxin production, the CAMP factor was tested for both Streptococcus 
species. 
The ability of S.uberis to grow in milk/ environment was assessed using the pauA factor 
probe, and in S.agalactiae, the fructose operons FO1 and FO3 were selected. For the study of 
bacteriocins, NU1, was chosen. 
 
Table XI- Virulence factors for S.agalactiae used in this study. 
Function and name Gene Reference 
Adhesion - Fibrinogen binding protein fbsB Jacobsson et al., 2003 
Ability to growth in milk/environment- Frutose operon fruD Richards et al., 2011 
Ability to growth in milk/environment- Frutose operon fruR Richards et al., 2011 
Toxin- CAMP factor cfb Chen et al., 2005 
 
Table XII- Virulence factors for S.uberis used in this study. 
Function and name Gene Reference 
Adhesion and invasion- S.uberis adhesion molecule sua Almeida et al., 2006 
Ability to growth in milk/environment- Plasminogen activator pauA 
Rosey et al., 1999; Ward &  
Leight, 2002 
Toxin- CAMP factor cfu Reinoso et al., 2011 
Bacteriocin- Nisin U nsu Wirawan et al., 2006 
 
In S.agalactiae membranes, (Table XI), the results obtained with the fbsB probe 
revealed that this gene was present in 95.3% (102/107) of the strains. Three strains (2.8%) 
have an average probability to have the gene, and two isolates (1.9%) were negative 
suggesting that these isolates do not have the fbsB gene.  
Results from the CAMP factor marker, showed that 95.3% (102/107) of the isolates were 
positive for this gene, four (3.7%) have an average probability and one isolate (0.9%) was 
negative for this gene. 
Markers from fructose operons revealed that for FO1, 92.5% (99/107) of the tested 
isolates have the gene, four isolates (3.7%) have an average probability and four isolates 
(3.7%) were negative for the presence of FO1. For the markers FO3, 98.1% of the isolates 
studied (105/107) were positive for the presence of this gene with high probability values and 
1.9% have an average probability. 
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Table XIII- Probability values of the results obtained from the Dot-Blot assays from S.agalactiae membranes 
Strain FO3 FO1 fbsb CAMP A1 F1SAA9 COW TEAT SCC AGENTS HC DATE CODE 
SA253 1,00 1,00 1,00 1,00 0,99 0,98 19 ALL 253 
 
AGX22 Dez.2013 1 
SA329 1,00 1,00 1,00 1,00 0,82 0,99 19 AD 679 SCN AGX22 Jan.2014 1 
SA335 1,00 1,00 1,00 1,00 0,40 0,99 19 AD 2106 
 
AGX22 Mar.2014 1 
SA254 1,00 1,00 1,00 1,00 1,00 1,00 35 ALL 92 
 
AGX22 Dez.2013 1 
SA322 1,00 1,00 1,00 1,00 0,96 1,00 35 AE 243 SCN AGX22 Jan.2014 1 
SA344 1,00 1,00 0,98 0,98 0,45 1,00 35 ALL 180 
 
AGX22 Abr.2014 1 
SA202 1,00 0,97 0,30 0,98 0,34 1,00 45 AD 2666 
 
AGX22 Dez.2013 3 
SA203 1,00 1,00 0,70 1,00 0,99 1,00 45 PD 3609 
 
AGX22 Dez.2013 3 
SA204 1,00 1,00 0,98 1,00 0,61 1,00 45 AE 1575 
 
AGX22 Dez.2013 1 
SA205 0,88 0,98 0,20 0,92 0,78 0,85 45 PE 941 
 
AGX22 Dez.2013 4 
SA326 1,00 1,00 1,00 1,00 1,00 1,00 45 AD 835 STR AGX22 Jan.2014 1 
SA327 1,00 1,00 1,00 1,00 1,00 1,00 45 PD 1726 
 
AGX22 Jan.2014 1 
SA328 1,00 1,00 1,00 1,00 1,00 1,00 45 PE 2682 SCN AGX22 Jan.2014 1 
SA257 0,82 0,96 0,93 0,77 0,61 0,88 66 ALL 608 
 
AGX22 Dez.2013 1 
SA330 1,00 1,00 1,00 1,00 1,00 1,00 66 PD 263 SCN AGX22 Jan.2014 1 
SA331 1,00 1,00 1,00 1,00 1,00 1,00 66 PE 306 
 
AGX22 Jan.2014 1 
SA336 1,00 1,00 1,00 1,00 1,00 1,00 66 PD 510 SCN AGX22 Mar.2014 1 
SA337 1,00 1,00 1,00 1,00 1,00 1,00 66 PE 5935 SCN AGX22 Mar.2014 1 
SA154 1,00 1,00 1,00 1,00 0,83 1,00 74 ALL 271 
 
AGX22 Abr.2013 1 
SA194 1,00 1,00 1,00 1,00 1,00 1,00 74 AD 605 
 
AGX22 Dez.2013 1 
SA195 1,00 1,00 1,00 1,00 1,00 1,00 74 PD 1708 
 
AGX22 Dez.2013 1 
SA196 1,00 1,00 1,00 1,00 1,00 1,00 74 AE 1124 
 
AGX22 Dez.2013 1 
SA197 1,00 1,00 1,00 1,00 1,00 1,00 74 PE 800 
 
AGX22 Dez.2013 1 
SA323 1,00 1,00 1,00 1,00 1,00 1,00 74 AD 282 YST AGX22 Jan.2014 1 
SA324 1,00 1,00 1,00 0,96 1,00 1,00 74 PD 784 
 
AGX22 Jan.2014 1 
SA325 1,00 1,00 1,00 1,00 1,00 1,00 74 AE 565 SCN AGX22 Jan.2014 1 
SA258 0,97 1,00 1,00 0,97 1,00 0,90 77 ALL 222 
 
AGX22 Dez.2013 1 
SA319 1,00 1,00 1,00 1,00 1,00 1,00 77 AE 324 
 
AGX22 Jan.2014 1 
SA334 1,00 1,00 1,00 1,00 1,00 1,00 77 AE 251 SCN/ECO AGX22 Mar.2014 1 
SA346 1,00 1,00 1,00 1,00 1,00 1,00 77 ALL 197 
 
AGX22 Abr.2014 1 
SA255 1,00 1,00 1,00 1,00 1,00 1,00 478 ALL 8969 
 
AGX22 Dez.2013 1 
SA320 1,00 1,00 1,00 1,00 1,00 1,00 478 AE 341 SCN AGX22 Jan.2014 1 
SA321 1,00 1,00 1,00 1,00 1,00 1,00 478 PE 2545 SAR AGX22 Jan.2014 1 
SA333 1,00 1,00 1,00 1,00 1,00 1,00 478 AE 192 SCN AGX22 Mar.2014 1 
SA345 1,00 1,00 1,00 1,00 1,00 1,00 478 ALL 720 
 
AGX22 Abr.2014 1 
SA318 1,00 1,00 1,00 1,00 1,00 1,00 53 ALL 427 SCN AGX22 Jan.2014 1 
SA343 1,00 1,00 1,00 1,00 0,98 1,00 53 ALL 285 
 
AGX22 Abr.2014 1 
SA38 1,00 1,00 1,00 1,00 1,00 1,00 8 ALL 253 
 
ASS74 Dez.2012 1 
SA275 1,00 1,00 1,00 1,00 1,00 1,00 8 AD 10077 
 
ASS74 Jan.2014 1 
SA276 1,00 1,00 1,00 1,00 1,00 1,00 8 AE 214 STR ASS74 Jan.2014 1 
SA277 1,00 1,00 1,00 1,00 1,00 1,00 8 PE 444 STR/SCN ASS74 Jan.2014 1 
SA221 1,00 1,00 1,00 1,00 1,00 1,00 26 PD 949 
 
ASS74 Dez.2013 1 
SA222 1,00 1,00 1,00 1,00 1,00 1,00 26 PE 135 
 
ASS74 Dez.2013 1 
SA283 1,00 1,00 1,00 1,00 1,00 1,00 26 AD 501 SAR ASS74 Jan.2014 1 
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SA284 1,00 1,00 1,00 1,00 1,00 1,00 26 PD 330 
 
ASS74 Jan.2014 1 
SA285 1,00 1,00 1,00 0,95 1,00 1,00 26 AE 223 
 
ASS74 Jan.2014 1 
SA286 1,00 1,00 1,00 1,00 1,00 1,00 26 PE 1393 SCN ASS74 Jan.2014 1 
SA67 1,00 1,00 1,00 1,00 1,00 1,00 29 AD 15719 
 
ASS74 Dez.2012 1 
SA68 1,00 1,00 1,00 1,00 1,00 1,00 29 ALL 9153 
 
ASS74 Dez.2012 1 
SA232 1,00 1,00 1,00 1,00 1,00 1,00 29 AE 896 
 
ASS74 Dez.2013 1 
SA233 1,00 1,00 1,00 1,00 1,00 1,00 29 PE 83 
 
ASS74 Dez.2013 1 
SA270 1,00 1,00 1,00 1,00 1,00 1,00 29 AD 57 
 
ASS74 Jan.2014 1 
SA271 1,00 1,00 1,00 1,00 1,00 1,00 29 PD 4888 STR ASS74 Jan.2014 1 
SA243 0,94 1,00 1,00 1,00 1,00 0,99 30 PD 201 
 
ASS74 Dez.2013 1 
SA244 1,00 1,00 1,00 1,00 1,00 1,00 30 PE 621 
 
ASS74 Dez.2013 1 
SA295 1,00 1,00 1,00 1,00 1,00 1,00 30 PE 2299 
 
ASS74 Jan.2014 1 
SA35 1,00 1,00 1,00 1,00 1,00 1,00 44 ALL 56 
 
ASS74 Dez.2012 1 
SA223 1,00 1,00 1,00 1,00 1,00 1,00 44 PE 6545 
 
ASS74 Dez.2013 1 
SA296 1,00 1,00 1,00 1,00 1,00 1,00 44 PE 3281 
 
ASS74 Jan.2014 1 
SA249 1,00 1,00 1,00 1,00 1,00 1,00 57 AD 616 SCN/YST ASS74 Dez.2013 1 
SA250 1,00 1,00 1,00 1,00 1,00 1,00 57 PD 248 
 
ASS74 Dez.2013 1 
SA251 1,00 1,00 1,00 1,00 1,00 1,00 57 AE 200 
 
ASS74 Dez.2013 1 
SA252 1,00 1,00 1,00 1,00 1,00 1,00 57 PE 1134 
 
ASS74 Dez.2013 1 
SA307 1,00 1,00 1,00 1,00 1,00 1,00 57 AD 2641 SCN ASS74 Jan.2014 1 
SA308 1,00 1,00 1,00 1,00 1,00 1,00 57 PD 341 
 
ASS74 Jan.2014 1 
SA309 1,00 1,00 1,00 1,00 1,00 1,00 57 AE 287 
 
ASS74 Jan.2014 1 
SA310 0,94 1,00 0,99 0,96 1,00 0,91 57 PE 1857 SCN ASS74 Jan.2014 1 
SA218 1,00 1,00 1,00 1,00 1,00 1,00 81 AE 410 
 
ASS74 Dez.2013 1 
SA219 1,00 1,00 1,00 1,00 1,00 1,00 81 PE 239 
 
ASS74 Dez.2013 1 
SA266 1,00 1,00 1,00 1,00 1,00 1,00 81 AE 810 
 
ASS74 Jan.2014 1 
SA267 1,00 1,00 1,00 1,00 1,00 1,00 81 PE 3637 
 
ASS74 Jan.2014 1 
SA234 1,00 1,00 1,00 1,00 1,00 1,00 121 PE 138 
 
ASS74 Dez.2013 1 
SA306 1,00 1,00 1,00 1,00 1,00 1,00 121 PE 558 SCN/STR ASS74 Jan.2014 1 
SA56 1,00 1,00 1,00 1,00 1,00 1,00 866 ALL 328 
 
ASS74 Dez.2012 1 
SA245 1,00 1,00 1,00 1,00 1,00 1,00 866 AD 106 
 
ASS74 Dez.2013 1 
SA246 1,00 1,00 1,00 1,00 1,00 1,00 866 PD 44 
 
ASS74 Dez.2013 1 
SA247 1,00 1,00 1,00 1,00 1,00 1,00 866 AE 115 
 
ASS74 Dez.2013 1 
SA248 1,00 1,00 1,00 1,00 1,00 1,00 866 PE 69 FUN ASS74 Dez.2013 1 
SA312 1,00 1,00 1,00 1,00 1,00 1,00 866 PD 126 SCN ASS74 Jan.2014 1 
SA313 1,00 1,00 1,00 1,00 1,00 1,00 866 AE 93 SCN ASS74 Jan.2014 1 
SA314 1,00 1,00 1,00 1,00 1,00 1,00 866 PE 50 
 
ASS74 Jan.2014 1 
SA207 0,76 0,24 0,73 0,87 0,32 0,75 714 ALL 50 
 
ASS74 Dez.2013 6 
SA260 1,00 0,98 0,98 1,00 0,97 1,00 714 AE 317 
 
ASS74 Jan.2014 1 
SA224 0,71 0,44 0,75 0,88 0,82 0,90 901 AD 1306 
 
ASS74 Dez.2013 7 
SA225 1,00 0,96 0,99 1,00 0,92 1,00 901 PD 492 
 
ASS74 Dez.2013 1 
SA226 0,98 0,94 0,98 1,00 0,97 0,93 901 AE 221 
 
ASS74 Dez.2013 1 
SA227 0,99 0,85 0,99 1,00 0,91 0,97 901 PE 1012 
 
ASS74 Dez.2013 1 
SA302 1,00 0,98 0,86 0,98 0,98 0,93 901 AD 136 
 
ASS74 Jan.2014 1 
SA303 1,00 0,99 0,98 0,99 0,63 1,00 901 PD 118 
 
ASS74 Jan.2014 1 
SA304 0,85 0,97 0,88 1,00 0,97 0,94 901 AE 74 
 
ASS74 Jan.2014 1 
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SA305 0,95 0,93 0,95 0,97 0,41 0,99 901 PE 373 STR ASS74 Jan.2014 1 
SA50 1,00 0,99 1,00 1,00 0,98 1,00 916 ALL 1815 
 
ASS74 Dez.2012 1 
SA237 0,99 0,94 0,99 0,95 0,91 1,00 916 AD 1332 
 
ASS74 Dez.2013 1 
SA238 1,00 0,97 0,99 1,00 0,96 1,00 916 PD 1092 
 
ASS74 Dez.2013 1 
SA239 1,00 0,57 0,98 1,00 0,98 0,95 916 AE 323 ETB ASS74 Dez.2013 8 
SA240 1,00 0,04 0,08 0,29 0,94 0,21 916 PE 828 
 
ASS74 Dez.2013 9 
SA57 1,00 0,97 1,00 0,02 0,99 1,00 917 ALL 254 
 
ASS74 Dez.2012 10 
SA300 1,00 1,00 1,00 1,00 1,00 1,00 917 AD 114 
 
ASS74 Jan.2014 1 
SA59 1,00 1,00 1,00 1,00 0,99 1,00 919 ALL 132 
 
ASS74 Dez.2012 1 
SA241 1,00 1,00 1,00 1,00 0,96 1,00 919 PD 249 
 
ASS74 Dez.2013 1 
SA242 1,00 0,90 1,00 1,00 0,97 1,00 919 AE 242 
 
ASS74 Dez.2013 1 
SA280 1,00 0,15 1,00 1,00 1,00 1,00 919 AD 355 SCN/STR ASS74 Jan.2014 11 
SA281 1,00 0,09 1,00 0,10 1,00 1,00 919 PD 11200 
 
ASS74 Jan.2014 12 
SA282 0,99 0,40 1,00 0,97 0,98 1,00 919 AE 241 SCN ASS74 Jan.2014 8 
SA43 0,82 0,92 1,00 0,04 0,96 1,00 920 ALL 91 
 
ASS74 Dez.2012 10 
SA214 0,66 0,64 0,81 0,70 0,77 1,00 920 PD 427 
 
ASS74 Dez.2013 13 
SA301 0,96 0,98 1,00 1,00 0,99 1,00 920 AD 1268 SCN ASS74 Jan.2014 1 
SCN-Estaphilococcus coagulase negativa, STR- Streptococcus,spp, ETB- Enterobacteriaceae, FUN- Fungi, YST- 
Yeast, SAR- Staphilococcus aureus, ECO- Escherichia coli.  AXG22- farm F, ASS74- farm A. 
 
Concerning S.uberis membrane, (Table XIV), the sua marker is present in 95.7% (45/47) 
of the isolates, and two isolates (4.3%) have an average probability. Concerning bacteriocin 
production, NU1 was present in 89.4% (42/47) of the isolates and five strains (10.6%) do not 
have this gene. 
Finally none of the S.uberis isolates (100%) presented the CAMP factor gene and the 
pauA gene was present in all strains (100%) evaluated. 
 
Table XIV- Probability values of the results obtained from the Dot-Blot assays from S.agalactiae membranes 
Strain ermB sua pauA NU1 CAMP F1SAA9 COW TEAT SCC AGENTS HC DATE CODE 
SU57 0,10 0,66 1,00 0,03 0,00 1,00 35 AD 5147 
 
AS5N9 Dez.2013 1 
SU91 0,91 0,98 1,00 0,21 0,00 1,00 35 AD 2417 ECO AS5N9 Fev.2014 2 
SU114 0,04 0,96 1,00 0,00 0,00 1,00 35 ALL 135 
 
AS5N9 Abr.2014 3 
SU52 0,88 0,96 1,00 1,00 0,00 1,00 65 AD 307 
 
AS5N9 Nov.2013 4 
SU53 0,72 0,86 1,00 1,00 0,00 1,00 65 AE 230 
 
AS5N9 Nov.2013 5 
SU58 0,16 0,69 0,99 1,00 0,00 1,00 65 AD 374 
 
AS5N9 Dez.2013 6 
SU59 0,89 0,97 0,98 1,00 0,00 1,00 65 AE 216 
 
AS5N9 Dez.2013 4 
SU 16 0,01 0,91 1,00 0,11 0,00 0,99 50 ALL 541 
 
AS5N9 Jan.2013 3 
SU112 0,24 0,98 1,00 0,11 0,00 1,00 50 ALL 302 SCN AS5N9 Abr.2014 3 
SU90 0,08 0,98 1,00 0,00 0,00 1,00 75 PD 5498 
 
AS5N9 Fev.2014 3 
SU113 0,97 1,00 1,00 0,07 0,00 1,00 75 ALL 3457 SCN AS5N9 Abr.2014 2 
SU76 0,98 1,00 1,00 0,04 0,00 1,00 8 AD 201 
 
BG04N Jan.2014 2 
SU80 0,98 1,00 1,00 0,07 0,00 1,00 8 AD 142 
 
BG04N Fev.2014 2 
SU72 0,99 1,00 1,00 0,09 0,00 1,00 18 PD 165 
 
BG04N Jan.2014 2 
SU73 1,00 1,00 1,00 0,04 0,00 1,00 18 AE 1677 
 
BG04N Jan.2014 2 
SU89 1,00 1,00 1,00 0,15 0,00 1,00 18 PE 1156 SCN BG04N Fev.2014 2 
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SU70 1,00 1,00 1,00 0,13 0,00 1,00 622 AD 295 
 
BG04N Jan.2014 2 
SU86 0,99 1,00 1,00 0,11 0,00 1,00 622 AD 193 
 
BG04N Fev.2014 2 
SU63 0,92 0,96 1,00 0,04 0,00 0,96 629 AD 456 
 
BG04N Jan.2014 2 
SU64 0,95 0,95 0,97 0,02 0,00 1,00 629 PD 1309 
 
BG04N Jan.2014 2 
SU65 0,85 0,93 0,98 0,03 0,00 1,00 629 AE 223 
 
BG04N Jan.2014 2 
SU82 0,87 0,98 1,00 0,21 0,00 1,00 629 AD 1742 
 
BG04N Fev.2014 2 
SU83 1,00 1,00 1,00 0,15 0,00 1,00 629 PD 179 
 
BG04N Fev.2014 2 
SU67 0,89 1,00 1,00 0,03 0,01 1,00 811 AD 321 
 
BG04N Jan.2014 2 
SU103 0,99 1,00 1,00 0,09 0,00 1,00 811 ALL 334 
 
BG04N Abr.2014 2 
SU40 0,99 1,00 1,00 0,07 0,00 0,96 855 PD 1416 
 
BG04N Nov.2013 2 
SU62 0,90 0,98 1,00 0,21 0,00 0,97 855 ALL 747 
 
BG04N Jan.2014 2 
SU79 1,00 1,00 1,00 0,18 0,00 0,63 855 PD 731 
 
BG04N Fev.2014 2 
SU99 0,91 1,00 1,00 0,18 0,00 1,00 855 ALL 385 
 
BG04N Abr.2014 2 
SU66 1,00 1,00 1,00 0,11 0,00 1,00 901 AE 5297 
 
BG04N Jan.2014 2 
SU81 1,00 1,00 1,00 0,18 0,00 1,00 901 AE 20531 
 
BG04N Fev.2014 2 
SU105 1,00 1,00 1,00 0,28 0,00 1,00 901 ALL 511 
 
BG04N Abr.2014 2 
SU45 1,00 1,00 1,00 1,00 0,00 1,00 902 PE IM 
 
BG04N Nov.2013 4 
SU101 0,96 0,99 1,00 0,04 0,00 1,00 902 ALL 1151 
 
BG04N Abr.2014 2 
SU42 0,98 0,99 1,00 0,03 0,00 1,00 942 AD 519 
 
BG04N Nov.2013 2 
SU43 1,00 0,98 1,00 0,05 0,00 0,98 942 AE 372 SCN BG04N Nov.2013 2 
SU69 1,00 1,00 1,00 0,03 0,00 0,97 942 AD 3169 
 
BG04N Jan.2014 2 
SU85 1,00 1,00 1,00 0,05 0,00 1,00 942 AD 2122 
 
BG04N Fev.2014 2 
SU49 1,00 1,00 1,00 0,09 0,00 1,00 947 PE 173 
 
BG04N Nov.2013 2 
SU68 0,99 1,00 1,00 0,18 0,00 1,00 947 PD 799 
 
BG04N Jan.2014 2 
SU87 1,00 1,00 1,00 0,13 0,00 1,00 947 PD 562 
 
BG04N Fev.2014 2 
SU88 1,00 1,00 1,00 0,02 0,00 1,00 947 PE 1748 SCN BG04N Fev.2014 2 
SU104 1,00 1,00 1,00 0,05 0,06 1,00 947 ALL 1138 
 
BG04N Abr.2014 2 
SU60 1,00 1,00 1,00 0,04 0,00 0,98 950 PD 450 
 
BG04N Jan.2014 2 
SU61 1,00 1,00 1,00 0,04 0,00 0,93 950 AE 14223 
 
BG04N Jan.2014 2 
SU84 1,00 1,00 1,00 0,11 0,00 1,00 950 AE 409 
 
BG04N Fev.2014 2 
SU98 1,00 1,00 1,00 0,09 0,00 1,00 950 ALL 1519 
 
BG04N Abr.2014 2 
SCN-Estaphilococcus coagulase negative, ECO- Escherichia coli. AS5N9- farm E, BG04N- farm Z. 
 
3.3- Antibiotics resistance marker 
In this study, the erythromycin resistance gene ermB, was analyzed in S.uberis, and the 
results revealed a positive hybridization of 85.1% (40/47) from all the collected isolates, a 
negative hybridization in 12.3% (6/47) of the isolates, and an average hybridization in only one 
(2.13%) S.uberis isolate. 
Interestingly, all the isolates that which were hybridization negative for ermB gene, were 
obtained from only one farm, i.e. farm E, located in Barcelos. 
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4- Genetic variation 
Due to the information collected about all the isolates obtained during the farm visits it 
was possible to trace the individual profiles of isolates present in each animal at a certain date. 
After evaluating the farms with animals mainly infected with S.uberis, it was possible to observe 
a high heterogeneity of isolates obtained from animals in farm E. For instance, the isolate SU57 
obtained in December 2013 from animal 35 had a hybridization value of 0.66 for the sua 
marker, i.e. below the high probability values obtained for most of the other S.uberis isolates for 
this marker, including the isolate SU114 with a probability value of 0.96, obtained in April 2014 
from the same animal. However, a different hybridization pattern was found for another isolate 
(SU91) obtained from the same animal in February 2014, which revealed positive hybridizations 
to markers ermB, sua, pauA and F1SAA9 and negative hybridizations for NU1 and CAMP 
markers. 
Concerning animal 65 the two isolates (SU52 and SU53) obtained in the visit of 
November 2013 showed the same hybridization profile, while the two isolates (SU58 and SU59) 
obtained one month later, i.e. in December 2013 were different with the isolate SU59 showing 
the same hybridization result as the isolates SU52 and SU53 obtained one month earlier, 
suggesting that this isolate might belong to the same clonal lineage as the isolates SU52 and 
SU53. In animal 50, isolates with the same hybridization pattern were obtained in both visits. On 
the contrary, in animal 75, two different hybridization profiles were obtained for the two isolates 
obtained in different visits (Table XIV). 
  Concerning farm Z, the results were very different, showing a strong homogeneity of 
isolates as almost all the animals studied originates isolates with identical hybridization signals 
regardless the visit, which suggests bacteria with a resilient behavior. The following pattern was 
repeated for the isolates obtained from every animal, positive hybridization for ermB, sua, pauA 
and F1SAA9 markers and negative hybridization for NU1 and CAMP markers. The only 
exception was cow number 902 which presented two isolates, one with an hybridization pattern 
equal to the one mentioned above and the other, collected in November 2013 (SU45), showed 
positive hybridization for the NU1 marker (Table XIV). 
Regarding farms mainly affected with S.agalactiae, in farm F the animals 19, 35, 53, 66, 
74, 77 and 478 presented high homogeneity with positive hybridization for all markers tested. 
The only exception found was animal 45, from which four isolates (SA202, SA203, SA204 and 
SA205) were obtained in December 2013. Interestingly all these isolates had different 
hybridization probabilities for fbsB marker, with 0.30 for isolate SA202; 0.70 for isolate SA203; 
0.90 for isolate SA204 and 0.20 for isolate SA205. These results seem to suggest that different 
S.agalactiae lineages were infecting simultaneously the same cow. However, one month later, 
in January 2014, the isolates obtained from three teats of this animal (cow 45), revealed an 
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identical values of hybridization probability, positive to all markers assayed, suggesting that the 
three teats were colonized by the same S.agalactiae lineage. 
In farm A, the animals 8, 26, 29, 30, 44, 57, 81, 121 and 866 present high homogeneity 
between isolates, with positive hybridization for all markers in the visits carried out. 
Nevertheless, exceptions were noticed in five cows. In animal 714, isolate SA207 obtained in 
December 2013, presented a negative hybridization for the FO1 marker and hybridization 
probability of 0.73 for fbsB. In the January 2014, the isolate SA260 obtained from the same 
animal was positive for all markers. These results suggest that, this cow presented putatively 
two different S.agalactiae lineages at two different time points. In animal 901, during the 
December 2013 visit, all the teats were sampled and further analysis revealed that isolate 
SA224 had hybridization probability values for FO3 and FO1 markers of 0.71 and 0.44 
respectively. The isolates from the remaining teats and the ones collected in January 2014 
showed hybridization probabilities close to 1 for all virulence markers. 
In animal 916, isolates SA50, SA237 and SA 238 had high hybridization signals for all 
markers, however SA239 presented an hybridization probability of 0.57 for the FO1 marker, and 
SA 240 revealed a negative hybridization for FO1 and fbsB markers and a weak hybridization 
probabilty of 0.29 for CAMP probe. This data suggest that in the same visit (December 2013) 
this animal was infected by three different S.agalactiae lineages. Animal number 917 revealed 
two distinct isolates in December 2012 (SA57) and in January 2014 (SA300). While the isolate 
SA57 was positive for all markers, with the exception for CAMP factor, the isolate SA300 was 
also positive for CAMP. 
In animal 919, strains SA59, SA241 and SA242 were positive to all markers, but in the 
visit of January 2014, the isolates obtained were different, with SA280 negative for marker FO1; 
SA281  negative for FO1 and CAMP and SA282 with a hybridization probability of 0.40 for FO1 
marker. These results suggest that in January 2014 three different S.agalactiae were infecting 
this animal.  
Finally, animal 920 presented three isolates with different hybridization patterns obtained 
at distinct dates: December 2012 (SA43); December 2013 (SA214); and January 2014 (SA301). 
Concerning, the persistence of mastitis caused by S.agalactiae, the data gathered 
showed that, in farm A, 60% of the cows had an infected persistent quarter, and in farm F, 75% 
of the animals presented the same infected quarters (Table I- appendix). About persistence in 
S.uberis farms, in farm E, 50% of animals had persistent quarters, and in farm Z, 72.7% of the 
cows revealed persistence of mastitis (Table XV). 
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Table XV- CMT and isolates results from selected Streptococcus uberis cows. 
Strain ANIMAL TEAT 
TCM Isolados 
HC DATE CODE TX 
AD PD AE PE AD PD AE PE 
SU57 35 AD 1A 0 0 0 1 
   
AS5N9 Dez.2013 1 
 
SU91 35 AD - - - - 2 
   
AS5N9 Fev.2014 2 
 
SU114 35 TODOS 0 0 0 0 3 3 3 3 AS5N9 Abr.2014 3 
 
SU52 65 AD 2 S 2 2 4 
 
5 
 
AS5N9 Nov.2013 4 
 
SU58 65 AD 1 S 2 2 6 
 
4 
 
AS5N9 Dez.2013 6 
 
SU 16 50 TODOS - - - - 3 3 3 3 AS5N9 Jan.2013 3 
 
SU112 50 TODOS 0 0 1 0 3 3 3 3 AS5N9 Abr.2014 3 SY (Fev e Mar) 
SU90 75 PD - - - - 
 
3 
  
AS5N9 Fev.2014 3 SY /YO/VO 
SU113 75 TODOS 0 2 0 0 2 2 2 2 AS5N9 Abr.2014 2 
 
SU76 8 AD 1 1 0 0 2 
   
BG04N Jan.2014 2 
 
SU80 8 AD 0 0 0 0 2 
   
BG04N Fev.2014 2 
 
SU72 18 PD 1 0 2 0 
 
2 2 
 
BG04N Jan.2014 2 
 
SU89 18 PE 2 2 2 2 
   
2 BG04N Fev.2014 2 
 
SU70 622 AD 2 0 2 0 2 
   
BG04N Jan.2014 2 
 
SU86 622 AD 1 0 0 S 2 
   
BG04N Fev.2014 2 
 
 
622 TODOS 1 0 2 S 
    
BG04N Abr.2014 
  
SU63 629 AD 2 1 0 2 2 2 2 
 
BG04N Jan.2014 2 
 
SU82 629 AD 2 0 0 2 2 2 
  
BG04N Fev.2014 2 
 
 
629 TODOS 2 1 1 2 
    
BG04N Abr.2014 
  
SU67 811 AD 2 0 0 2 2 
   
BG04N Jan.2014 2 
 
SU103 811 TODOS 2 1 2 1 2 2 2 2 BG04N Abr.2014 2 
 
SU40 855 PD 2 2 1 0 
 
2 
  
BG04N Nov.2013 2 
 
SU62 855 TODOS 2 2 2 0 2 2 2 2 BG04N Jan.2014 2 
 
SU79 855 PD 0 0 0 0 
 
2 
  
BG04N Fev.2014 2 
 
SU99 855 TODOS 2 2 S 1 2 2 2 2 BG04N Abr.2014 2 
 
SU66 901 AE 0 0 2 0 
  
2 
 
BG04N Jan.2014 2 
 
SU81 901 AE 0 0 1B 0 
  
2 
 
BG04N Fev.2014 2 
 
SU105 901 TODOS 1 1 2 1 2 2 2 2 BG04N Abr.2014 2 
 
SU45 902 PE 1 2 0 2 
   
4 BG04N Nov.2013 4 
 
 
902 PE 2 2 2 1 
    
BG04N Jan.2014 
  
SU101 902 TODOS 2 2 2 2 2 2 2 2 BG04N Abr.2014 2 
 
SU42 942 AD 2 2 2 2 2 
 
2 
 
BG04N Nov.2013 2 
 
SU69 942 AD 2 2 2 2 2 
   
BG04N Jan.2014 2 
 
SU85 942 AD 2 2 2 2 2 
   
BG04N Fev.2014 2 
 
SU49 947 PE 0 2 0 2 
   
2 BG04N Nov.2013 2 
 
SU68 947 PD 0 0 1 2 
 
2 
  
BG04N Jan.2014 2 
 
SU87 947 PD 0 2 1 2 
 
2 
 
2 BG04N Fev.2014 2 
 
SU104 947 TODOS 2 2 2 2 2 2 2 2 BG04N Abr.2014 2 
 
SU60 950 PD 0 1A 0 1 
 
2 2 
 
BG04N Jan.2014 2 
 
SU84 950 AE 2 2 2 1 
  
2 
 
BG04N Fev.2014 2 
 
SU98 950 TODOS 1 2 1 1 2 2 2 2 BG04N Abr.2014 2 
 
SY- Synulox, YO- Yodimaspen, VO- Voren. 
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5- Search for pathogens in cow`s environment 
In order to search for pathogens in cow’s environment, swabs were performed in the teat 
cups, milkers’ hands and sawdust in all the farms visited. The results are shown in Table XIV. 
None of isolates obtained were identified as S.agalactiae or S.uberis, however, the pathogens 
detected could act as a gateway for those mastitis causative pathogens. 
 
Table XIV- Results from swabs collected in farms A (S.agalactiae) and Z (S.uberis). 
Herd Date Local Bacteriology 1 Bacteriology 2 Bacteriology 3 
A jan/14 MILKER HANDS 1 BM Sta.aureus/intermedi Streptococcus spp Escherichia coli 
A jan/14 MILKER HANDS 2 BM Negative cultures - - 
A jan/14 TEAT CUP 1 LS BM Estaf.coag.neg Streptococcus spp Escherichia coli 
A jan/14 TEAT CUP 9 LS BM Sta.aureus/intermedi Streptococcus spp Escherichia coli 
A jan/14 TEAT CUP 11 LS BM Sta.aureus/intermedi Streptococcus spp Escherichia coli 
A jan/14 TEAT CUP 1 RS BM Sta.aureus/intermedi Streptococcus spp Escherichia coli 
A jan/14 TEAT CUP 6 RS BM Sta.aureus/intermedi Streptococcus spp Escherichia coli 
A jan/14 TEAT CUP 1 RS AM Sta.aureus/intermedi Estaf.coag.neg Escherichia coli 
A jan/14 TEAT CUP 6 RS AM Sta.aureus/intermedi Streptococcus spp Escherichia coli 
A jan/14 MILKER HANDS AM Streptococcus spp Bacillus spp - 
Z Feb /14 MILKER HANDS 1 BM Estaf.coag.neg - - 
Z Feb /14 MILKER HANDS 2 BM Streptococcus spp Estaf.coag.neg - 
Z Feb /14 TEAT CUP 1 RS BM Negative cultures - - 
Z Feb /14 TEAT CUP 3 RS BM Negative cultures - - 
Z Feb /14 TEAT CUP 7 RS BM Negative cultures - - 
Z Feb /14 TEAT CUP 2 LS BM Negative cultures - - 
Z Feb /14 TEAT CUP 1 RS AM Streptococcus spp Estaf.coag.neg Enterococcus spp 
Z Feb /14 TEAT CUP 3 RS AM Streptococcus spp Estaf.coag.neg Bacillus spp 
Z Feb /14 TEAT CUP 7 RS AM Enterococcus spp Estaf.coag.neg - 
Z Feb /14 TEAT CUP 2 LS AM Estaf.coag.neg Streptococcus spp - 
Z Feb /14 MILKER HANDS  1 AM Enterococcus spp Estaf.coag.neg Streptococcus spp 
Z Feb /14 MILKER HANDS  2 AM Estaf.coag.neg - - 
Z Feb /14 UNUSED SAWDUST Leveduras - - 
Z Feb /14 
LACTATION COWS 
SAWDUST Streptococcus spp Estaf.coag.neg - 
Z Feb /14 DRY COWS SAWDUST Sta.aureus/intermedi Streptococcus spp Fungos 
RS- Right side; LS- Left side; BM- Before milking; AM- After milking 
 
DISCUSSION 
 
1.  Mastitis in herds 
 
Despite all efforts undertaken by farmers to apply good practices in management and 
control of mammary infections, caused by pathogens like S.agalactiae and S.uberis in herds, in 
this work it was possible to determine that there is still a high prevalence of these pathogens in 
those farms.   
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In order to better understand outbreaks of S.agalactiae and S.uberis it is important to 
conduct epidemiological studies taking into account, several other factors, namely, cow´s 
genetics, bacterial virulence factors and specific mastitis control programs. 
In this work, the genotypic properties of numerous strains isolated from cows of four 
dairy farms in monthly visits, as well as clinical information regarding these same cows were 
evaluated, aiming to define bacterial virulence characteristics, strategies for host invasion, and 
persistence in herds.  
The data collected in this study showed that the mean SCC is higher in infections 
caused by S.uberis isolates, suggesting that this species could cause a more severe mammary 
gland inflammation, which requires better therapeutic care to control the infection and the 
spreading to other animals.  However, S.agalactiae isolates have a wide range of infection, i.e. 
the highest and the lowest score of SCC, and for that reason clinical signs could be very 
different, ranging from mild or severe mastitis. Therefore, veterinarians should be aware of this 
variation in order to better plan the therapeutic control. Regarding genotypic properties of the 
isolates, we were able to observe that, S.uberis isolates that presented code 2 (positive signal 
hybridization for the sua and pauA markers and negative signal hybridization for the ermB, NU1 
and CAMP markers), were the most commonly found in herds. On the other hand, code 1 
S.uberis isolates presented a higher SCC, suggesting that this genotype could be more virulent 
than the others. Nevertheless, the most common genotype that was found did not present a 
very high SCC, and can be easily controlled with prophylactic measures. Concerning S. 
agalactiae isolates, the most common genotype is represented by the code 1 (positive signal 
hybridization with all markers), which have an average SCC that could easily decrease with 
appropriate drugs. The only isolate that presented a very high SCC is represented by code 12; 
suggesting that this type of strain could be very virulent for the mammary gland. Isolates with 
codes 10 and 6 presented a very low SCC and easily pass unnoticed under the threshold of 
mastitis detection. For this reason, veterinarians should not discard samples with these SCC 
values and should always perform a thorough analysis of available samples. 
 
2. DNA- based identification of pathogens 
The taxa-specific markers F1SAA9 and A1 correctly identified all Streptococcaceae and 
S.agalactiae, respectively. In general the results presented in this work, reinforce the good 
stability and consistency of these markers to be used in identification of Streptococcaceae, 
S.agalactiae and S.uberis. 
  Regarding the genes coding for adherence and invasion traits of bacteria to the host 
epithelial cells, the fbsB gene in S.agalactiae and the sua gene in S.uberis, the results obtained 
in this study showed that about 97.2% of the S.uberis isolates have a strong probability to 
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contain the sua gene. These results differ from other studies, showing that sua was not present 
in 20% of S.uberis strains isolated from cows with mastitis (Reinoso et al, 2011). The high 
presence of this sua in S.uberis isolates, may suggest that this gene plays an important role in 
establishing infection. 
The fructose operons, fruD and fruR, were present in S.agalactiae in a rate of 98.1% and 
92.5%, respectively. The ability to use fructose to obtain carbon sources is important for this 
bacteria to survive outside the mammary gland and, therefore, the presence of these markers, 
might be considered to confer an adaptative advantage to the dissemination of the infection.  
Another operon that may provide competitive advantages during mastitis infections is the 
nisin U operon. In this study, this marker was present in 89.4% of the S.uberis strains 
evaluated. These results show that this bacteriocin might confer dominance to S.uberis when 
competing with other species (Pryor et al., 2009). Interestingly these results contrast to previous 
research where the presence of genes from the nisin U operon was limited to a few strains 
(Wirawan et al., 2006). 
Regarding the ability to growth in milk, pauA was evaluated in S.uberis isolates, and all 
the strains presented a positive hybridization signal in dot blot assays. The presence of this 
gene is acknowledge to confer an advantage for this species to persist in the mammary glands, 
despite the flushing effect of milk during milking. 
In relation to toxin production the CAMP factor was tested for both S.agalactiae and 
S.uberis. 
The dot blot assays, revealed that none of the tested S.uberis isolates presented this 
gene, whereas, 95.3% of S.agalactiae isolates presented this gene. It is worth mentioning that 
CAMP factor assay is used as a presumptive identification of S.agalactiae, therefore, it is not 
surprising that the majority of S.agalactiae isolates were positive for this marker, contrary to 
what was observed for the S.uberis isolates. 
The ermB antibiotic resistance coding gene was observed to be present in 85.1% of all 
S.uberis isolates studied. Besides the therapeutic informative value, these results confirm the 
spread and emergence of the macrolide resistance in the environment. 
Briefly, altogether this study emphasizes the presence of diverse S.agalactiae and 
S.uberis genotypes associated with bovine mammary gland infections. The results further 
suggest the existence of isolates characterized by different virulence patterns, some of which 
obtained from the same animal at different time points. The high frequency of these virulence 
factors in the dozens of streptococci isolates analyzed suggest that bacteria possessing these 
genomic traits, are more able to cause infection and persist in environment, and therefore more 
likely to successfully cause mastitis infections. The genetic variability in farms mainly affected 
with S.uberis is higher in farm E, and in farms mainly affected with S.agalactiae is higher in farm 
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A. These differences may be due to environment features and cow`s factors which might worth 
considering in future studies. 
 
3. Future perspectives 
The results obtained in this research should be analyzed with caution because, despite 
the reasonable number of bacterial isolates collected, a larger timeframe of the study would be 
important to obtain more isolates from the same cow across a longer period, to better 
understand bacterial adaptation and evolution. 
Nevertheless, regardless the inherent limitations, this study provide valuable information 
comprising epidemiological and molecular data, of these mastitis pathogens, which may 
contribute to improve treatment and containment measures. In addition this study contributed to 
disclose other research questions that will be important to address in future research, namely: 
 
 Continue to collect at different time points samples from cows that were previously 
diagnosed with clinical or subclinical mastitis caused by S.agalactiae and S.uberis 
carriers, in order to determine detailed an epidemiological profiles. The cows monitored 
in this study can be a starting point. 
 
 Investigate more genes coding for other virulence factors and antimicrobial resistance. 
 
 Infer the geographical, temporal and cow`s housing patterns of individual cows infected 
with these streptococci agents, and correlate them with bacteria genomic traits. 
 
 Gather as much as possible clinical information from infected cows, regarding their 
general health state, severity, persistence and antibiotics used and correlate this 
information with resistance to treatment, and bacterial properties. 
 
 Standardize all the information in a database, in order to make it easily accessible and 
understandable to additional epidemiological and molecular studies. 
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2. Table 
 
Table I- Appendix-  CMT and isolates results from selected Streptococcus agalactiae cows. 
Strain ANIMAL TEAT 
CMT Isolates 
HC DATE TX 
AD PD AE PE AD PD AE PE 
SA253 19 TODOS 2 0 0 0 1 1 1 1 AGX22 dez/13 
 
SA329 19 AD 1 0 0 0 1 
   
AGX22 jan/14 
 
SA335 19 AD 2 2 0 0 1 
   
AGX22 mar/14 
 
SA254 35 TODOS 0 0 0 0 1 1 1 1 AGX22 dez/14 
 
SA322 35 AE S 2 0 0 
  
1 
 
AGX22 jan/14 
 
SA344 35 TODOS S 0 2 1 3 3 3 3 AGX22 abr/14 
 
SA202 45 AD 1 2 2 2 3 3 1 4 AGX22 dez/13 
 
SA326 45 AD 1 2 0 2 1 1 
 
1 AGX22 jan/14 
 
SA257 66 TODOS 0 2 S 1 1 1 1 1 AGX22 dez/13 
 
SA330 66 PD 0 1 S 0 
 
1 
 
1 AGX22 jan/14 
 
SA336 66 PD 2 2 S 2 
 
1 
 
1 AGX22 mar/14 PM 
 
66 TODOS 2 2 S 2 
    
AGX22 abr/14 
 
SA154 74 TODOS - - - - 1 1 1 1 AGX22 abr/13 
 
SA194 74 AD 2 2 2 2 1 1 1 1 AGX22 dez/13 
 
SA323 74 AD 2 2 2 S 1 1 1 1 AGX22 jan/14 
 
SA258 77 TODOS 0 0 0 2 1 1 1 1 AGX22 dez/13 
 
SA319 77 AE 0 0 1 2 
  
1 
 
AGX22 jan/14 
 
SA334 77 AE 0 0 0 1 
  
1 
 
AGX22 mar/14 
 
SA346 77 TODOS 0 0 0 2 1 1 1 1 AGX22 abr/14 
 
SA255 478 TODOS 0 1 0 2 1 1 1 1 AGX22 dez/13 
 
SA320 478 AE 2 0 0 2 
  
1 1 AGX22 jan/14 
 
SA333 478 AE 0 1 0 0 
  
1 
 
AGX22 mar/14 
 
SA345 478 TODOS 0 0 2 0 1 1 1 1 AGX22 abr/14 
 
SA318 53 TODOS 0 0 2 2 1 1 1 1 AGX22 jan/14 OE 
SA343 53 TODOS 0 0 1 1 1 1 1 1 AGX22 abr/14 
 
VIII 
 
SA38 8 
 
2 2 1 2 1 1 1 1 ASS74 dez/12 
 
SA275 8 AD 2 2 0 2 1 
 
1 1 ASS74 jan/14 
 
cont 8 TODOS 0 2 0 0 
    
ASS74 abr/14 
 
SA221 26 PD 0 2 0 2 
 
1 
 
1 ASS74 dez/13 
 
SA283 26 AD 1 2 1 2 1 1 1 1 ASS74 jan/14 
 
SA67 29 
 
M 2 2 1 1 1 1 1 ASS74 dez/12 
 
SA233 29 PE 0 2 0 0 
  
1 1 ASS74 dez/13 
 
SA270 29 AD 0 2 1A 0 1 1 
  
ASS74 jan/14 
 
SA243 30 PD S 2 2 2 
 
1 
 
1 ASS74 dez/13 
 
SA295 30 PE S 2 2 2 
   
1 ASS74 jan/14 
 
SA35 44 TODOS M 0 0 0 1 1 1 1 ASS74 dez/12 
 
SA223 44 PE 1 0 0 2 
   
1 ASS74 dez/13 
 
SA296 44 PE 0 0 0 2 
   
1 ASS74 jan/14 
 
SA249 57 AD 2 2 2 2 1 1 1 1 ASS74 dez/13 
 
SA307 57 AD 2 2 2 2 1 1 1 1 ASS74 jan/14 
 
SA218 81 AE 0 0 0 1 
  
1 1 ASS74 dez/13 
 
SA266 81 AE 0 0 2 2 
  
1 1 ASS74 jan/14 
 
SA234 121 PE 0 0 0 2 
   
1 ASS74 dez/13 
 
SA306 121 PE 0 0 0 2 
   
1 ASS74 jan/14 
 
SA56 866 TODOS 0 2 0 0 1 1 1 1 ASS74 dez/12 
 
SA245 866 AD 0 0 0 0 1 1 1 1 ASS74 dez/13 
 
SA311 866 AD 0 1 0 0 
 
1 1 1 ASS74 jan/14 
 
SA207 714 TODOS 0 0 0 0 6 6 6 6 ASS74 dez/13 
 
SA260 714 AE 0 0 2 1 
  
1 
 
ASS74 jan/14 
 
SA224 901 AD 2 2 0 2 7 1 1 1 ASS74 dez/13 
 
SA302 901 AD 0 1 0 0 1 1 1 1 ASS74 jan/14 
 
SA50 916 TODOS 2 1 1 1 1 1 1 1 ASS74 dez/12 
 
SA237 916 AD 2 2 1 2 1 1 8 9 ASS74 dez/13 
 
SA57 917 TODOS 0 0 0 0 10 10 10 10 ASS74 dez/12 
 
SA300 917 AD 1B 0 0 0 1 
   
ASS74 jan/14 
 
SA59 919 TODOS 0 0 0 0 1 1 1 1 ASS74 dez/12 
 
SA241 919 PD 0 0 1 1 
 
1 1 
 
ASS74 dez/13 
 
SA280 919 AD 2 2 0 1 11 12 8 
 
ASS74 jan/14 
 
SA43 920 TODOS 0 0 0 0 10 10 10 10 ASS74 dez/12 
 
SA214 920 PD 0 2 2 2 
 
13 
  
ASS74 dez/13 
 
SA301 920 AD 0 2 0 0 10 
   
ASS74 jan/14 
 
PM- Penicilina Mista; OE- Orbenin Extra 
 
. 
 
 
 
 
 
 
 
 
